ChargePoint Holdings, Inc.
NYSE:CHPTSpecialty Retail
+$0.46 today
- Market cap
- $269.31M
- Beta
- 1.70
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$8.38
Volume 0.58M
Average 0.54M
CHPT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
ChargePoint Holdings, Inc.NYSE: CHPT
Research & Development · Q1 FY2027 · quarter ended Apr 2026
Research & development declines year over year
Q1 FY2027 research & development of $31.48M fell 6.1% year over year, behind the -1.1% change in trailing-twelve-month research & development. Sequentially, it fell 9.1% from the prior quarter. Over 3 fiscal years it compounded at -10.6% a year.
Context
- Research & development amounted to 33.9% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -6.1% toward the trailing-twelve-month pace of -1.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 139.27M USD
- Year-over-year change
- -1.4%
- 4-year CAGR
- -1.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 139.27M | -1.4% |
| FY2025 | 2025-01-31 | 141.28M | -36.0% |
| FY2024 | 2024-01-31 | 220.78M | +13.2% |
| FY2023 | 2023-01-31 | 194.96M | +34.4% |
| FY2022 | 2022-01-31 | 145.04M | — |
Research & Development vs competitors
How CHPT compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -1.1% is the 2nd highest of 6, against a peer median of -17.4%.
- Research & development amounts to 33.0% of revenue for CHPT, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $137.24M USD | -1.1% | -10.6% | 33.0% | |
| LTM Mar 2026 | $59.23M USD | -3.2% | +3.3% | 3.8% | |
| LTM Mar 2026 | $6.14M USD | +98.5% | — | 3.7% | |
| LTM Jun 2025 | €5.24M EUR | -17.4% | — | 1.8% | |
| LTM Mar 2026 | $400K USD | -84.2% | — | 0.0% | |
| LTM Jan 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CN¥0 CNY | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CHPT) | — | -17.4% | +3.3% | 0.0% | |
Competitors are the stored peer set for CHPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 242.34M | 468.09M | 506.64M | 417.08M | 411.22M |
| Cost of Revenue | 188.81M | 382.16M | 476.52M | 316.4M | 285.62M |
| Gross Profit | 53.53M | 85.93M | 30.12M | 100.68M | 125.6M |
| Gross Margin | 22.1% | 18.4% | 5.9% | 24.1% | 30.5% |
| Research & Development | 145.04M | 194.96M | 220.78M | 141.28M | 139.27M |
| Selling, General & Admin | 174.87M | 232.76M | 259.29M | 212.4M | 196.47M |
| Operating Expenses | 319.91M | 427.72M | 481.7M | 353.68M | 335.74M |
| Depreciation & Amortization | 20.7M | 29.79M | 28.49M | 29.19M | 30.36M |
| EBITDA | (117.21M) | (312.79M) | (412.87M) | (218.85M) | (179.78M) |
| EBITDA Margin | -48.4% | -66.8% | -81.5% | -52.5% | -43.7% |
| Operating Income | (266.38M) | (341.78M) | (449.95M) | (253M) | (210.14M) |
| Operating Margin | -109.9% | -73.0% | -88.8% | -60.7% | -51.1% |
| Interest Income | 98K | 5.53M | 9.6M | 8.35M | 4.49M |
| Interest Expense | 1.5M | 9.43M | 16.27M | 24.65M | 23.86M |
| Other Income / Expenses | 130.6M | (6.14M) | (7.68M) | (19.7M) | (6.01M) |
| Income Before Tax | (135.78M) | (347.92M) | (457.63M) | (272.69M) | (216.15M) |
| Pre-Tax Margin | -56.0% | -74.3% | -90.3% | -65.4% | -52.6% |
| Income Tax Expense | (3.54M) | (2.82M) | (21K) | 4.37M | 4.05M |
| Net Income | (132.57M) | (344.46M) | (457.61M) | (277.07M) | (220.2M) |
| Net Margin | -54.7% | -73.6% | -90.3% | -66.4% | -53.5% |
| EPS (Basic) | (9.00) | (20.40) | (24.40) | (12.78) | (9.41) |
| EPS (Diluted) | (8.80) | (20.40) | (24.40) | (12.78) | (9.41) |
| Weighted Avg Shares | 14.87M | 16.92M | 18.78M | 21.67M | 23.41M |
| Weighted Avg Shares (Diluted) | 15.12M | 16.92M | 18.78M | 21.67M | 23.41M |
ChargePoint Holdings, Inc.
NYSE:CHPT
Intrinsic Alpha fair value
Locked
Current Price
$10.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.